Results 121 to 130 of about 13,305 (193)

Metabolomic biomarkers and metabolic remodelling in genetically characterised hypertrophic cardiomyopathy: a systematic review. [PDF]

Metabolomics
Ahmad Razmy AH, Abd Latip N, Ab-Rahim S, Sheikh Abdul Kadir SH.   +3 more
europepmc   +1 more source

The skeletal muscle slow myosin heavy chain regulates mammalian metabolic homeostasis through the NRF2 pathway. [PDF]

Sci Adv
Sharma J, Mondal S, Rai A, Kumari M, Bharadwaj A, Mathew SJ.   +5 more
europepmc   +1 more source

Are clinical trajectories in obstructive hypertrophic cardiomyopathy mutation-specific? A systematic review and meta-analysis of <i>MYH7</i> vs. <i>MYBPC3</i>. [PDF]

Front Cardiovasc Med
Li Y, Yu J.
europepmc   +1 more source

Nr2f1a and Isl1 repress acquisition of epicardial identity in venous atrial cardiomyocytes. [PDF]

Development
Martin KE, Fernandes AT, Sayed M, Hanlon MA, Fallon S, Lim HW, Waxman JS.   +6 more
europepmc   +1 more source

Hypertrophic Cardiomyopathy Mutation R723G in MYH7 Enhances Its mRNA-Stability. [PDF]

Acta Physiol (Oxf)
Kowalski K, Schwarze L, Kraft T, Montag J.   +3 more
europepmc   +1 more source

Geographical and Ethnic Heterogeneity in Genetic Dilated Cardiomyopathies. [PDF]

Int J Mol Sci
Di Peppo M, Biancofiore G, Crudo AF, Gulino G, Costabile E, Margaglione A, D'Ambrosio MF, Correale M, Brunetti ND, Santacroce R, Margaglione M, Iacoviello M.   +11 more
europepmc   +1 more source

Puberty-Associated Emergence of Hypertrophic Cardiomyopathy: When Genetics Meets Growth. [PDF]

JACC Case Rep
Mashiah G, Schamroth N, Yaeger-Yarom G, Kapusta L, Lowenthal A.   +4 more
europepmc   +1 more source

Type-specific and hibernation-associated skeletal muscle remodeling of the back muscle in Syrian hamsters. [PDF]

J Physiol Sci
Matsuoka N, Yamauchi A, Yamaguchi Y.
europepmc   +1 more source

The Role of the OBSCN Gene in Cardiomyopathy: A Review of Molecular Mechanisms and Clinical Significance. [PDF]

J Cardiovasc Dev Dis
Chen J, Sun X, Wu S, Hu J, Zou Y, Hong K, Shen Y.   +6 more
europepmc   +1 more source

HDAC inhibition via suberoylanilide hydroxamic acid ameliorates doxorubicin-induced cardiotoxicity. [PDF]

Nat Commun
Eksi B, Finke D, Michel S, Brauer J, Heckmann MB, Valadan M, Schanze LM, Sunder V, Steimel K, Burhenne J, Seeger T, Katus HA, Frey N, Backs J, Lehmann LH.   +14 more
europepmc   +1 more source